安必平涨2.11%，成交额2680.01万元，主力资金净流出314.22万元

Group 1 - The core viewpoint of the news is that Anbiping's stock has shown fluctuations in price and trading volume, with a notable increase of 38.00% year-to-date, despite recent declines over the past 20 and 60 days [1][2] - As of December 25, Anbiping's stock price reached 23.75 yuan per share, with a market capitalization of 2.22 billion yuan and a trading volume of 26.80 million yuan [1] - The company has experienced a net outflow of 3.14 million yuan in principal funds, with significant selling pressure observed [1] Group 2 - Anbiping operates in the medical and biological industry, specifically in the medical device sector focusing on in vitro diagnostics [2] - For the period from January to September 2025, Anbiping reported a revenue of 253 million yuan, a year-on-year decrease of 28.29%, and a net profit attributable to shareholders of -10.77 million yuan, a decline of 136.34% [2] - The company has distributed a total of 87.80 million yuan in dividends since its A-share listing, with 36.46 million yuan distributed over the past three years [3]